I am an an Alzheimer's Association Research Fellow at the Wellcome Centre for Integrative Neuroimaging (WIN).
I am passionate about making research translational and applicable in clinical settings. My current project aims to translate research knowledge and quantitative measurements from brain MRI in memory clinic through the Oxford Brain Health Centre.
I am also involved in projects that aim to develop image analysis tools for clinical applications and to harmonise MRI-derived measures across sites/studies.
I am a member of the Translational Neuroimaging Group (TNG) and collaborate on studies on brain MRI analysis in ageing, Alzheimer’s disease, Parkinson’s disease and vascular disease, looking for early signs of dementia and neurodegeneration.
I co-lead the Dementias Platform UK (DPUK) Work Package 22: Image processing pipelines.
As a member of the WIN Analysis group I am also involved in the development of methodological approaches for structural MRI (automated lesions segmentation) and resting state fMRI (artefact removal and reproducibility assessments) part of the FSL image analysis software package.
I completed my undergraduate studies and a PhD in Bioengineering at Politecnico di Milano (Milan, Italy) before moving to University of Oxford as a postdoctoral researcher.
Teaching and Training
I am involved in post-graduate supervision and in teaching, both within the University of Oxford and at the international FSL course.
Normative models for neuroimaging markers: Impact of model selection, sample size and evaluation criteria.
Bozek J. et al, (2023), Neuroimage, 268
Identifying microstructural changes in diffusion MRI; How to circumvent parameter degeneracy.
Rafipoor H. et al, (2022), Neuroimage, 260
Adults with tetralogy of Fallot show specific features of cerebral small vessel disease: the BACH San Donato study.
Melazzini L. et al, (2022), Brain Imaging Behav, 16, 1721 - 1731
Resting-state, structural and diffusion MRI metrics related to fatigue in MS, MOGAD AND NMOSD
Camera V. et al, (2022), EUROPEAN JOURNAL OF NEUROLOGY, 29, 782 - 783
Association of cerebral small vessel disease burden with brain structure and cognitive and vascular risk trajectories in mid-to-late life.
Jansen MG. et al, (2022), J Cereb Blood Flow Metab, 42, 600 - 612